November 5, 2009 8:00 am – 6:00 pm

Boston University Trustee Ballroom 1 Silber Way, 9th Floor Boston, MA, USA 02115

This year marked the debut of the NCI SBIR Investor Forum, an exclusive event designed to connect the strongest and most promising NCI SBIR companies with biotechnology investors and strategic partners. This was a rare opportunity for attendees to get a first look at some of the best early-stage oncology companies currently funded by the NCI and provided opportunities to foster new and unique collaborations.

The event held November 5, 2009 was attended by over 150 leading investors and top pharmaceutical and medical device companies, all strategic partners in the effort to develop and commercialize novel technologies and products to prevent, diagnose, and treat cancer. The Forum showcased the top 14 SBIR companies focused on innovative research in cancer-related technologies, selected by strength of research, impact on cancer, product development and market potential. These breakthrough discoveries are primed for commercialization and will be the next generation of cancer therapeutics, imaging products, diagnostics, and other important technologies in the fight against cancer. Companies that presented were pre-screened by an independent panel of experts from venture capital firms, bio-pharmaceutical, and medical device companies. Company representatives were available for formal and informal networking to discuss their programs and partnership opportunities.

At the Forum, Investors and Strategic Partners:

• Learned about and met with a select group of small businesses that are developing innovative and groundbreaking diagnostic, therapeutic, bioinformatics, imaging products, and other cancer-related technologies
• Attended private breakout sessions with top SBIR-funded companies
• Met with NCI SBIR Development Center leadership to learn about the NCI SBIR Bridge Award, a unique $3 million funding opportunity to accelerate promising cancer-related technologies to commercialization
• Engaged with NCI SBIR Development Center staff to discuss upcoming funding and opportunities to leverage investments to catalyze the commercialization of cancer prevention, detection, and treatment technologies and therapeutics

This forum was sponsored by The National Cancer Institute's SBIR Development Center in partnership with Boston University's Office of Technology Development, and other collaborators.